Page last updated: 2024-11-07

spironolactone and Glucosephosphate Dehydrogenase Deficiency

spironolactone has been researched along with Glucosephosphate Dehydrogenase Deficiency in 1 studies

Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.

Glucosephosphate Dehydrogenase Deficiency: A disease-producing enzyme deficiency subject to many variants, some of which cause a deficiency of GLUCOSE-6-PHOSPHATE DEHYDROGENASE activity in erythrocytes, leading to hemolytic anemia.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Balderia, PG1
Wongrakpanich, S1
Patel, M1
Stanek, M1

Other Studies

1 other study available for spironolactone and Glucosephosphate Dehydrogenase Deficiency

ArticleYear
Healing the orphaned heart: heart failure in a patient with glucose-6-phosphate dehydrogenase deficiency.
    BMJ case reports, 2015, Mar-05, Volume: 2015

    Topics: Aged; Diuretics; Drug Therapy, Combination; Ethacrynic Acid; Female; Glucosephosphate Dehydrogenase

2015